Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangming Chen

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Frontiers in Cellular and Infection Microbiology|July 19, 2021
Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura PhenotypesYuanzhen Zhang, Guizhi Xia, Xiaojing Nie, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replicationGuangming Chen, Hongyu Ren, Anthony Turpoff, et al.
Elife|February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrheaJana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4BGuangming Chen, Hongyu Ren, Nanjing Zhang, et al.
Journal of Medicinal Chemistry|May 5, 2018
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative BacteriaAleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, et al.
Molecular Genetics & Genomic Medicine|May 30, 2023
New insights from trio whole-exome sequencing in the children with kidney disease: A single-center retrospective cohort studyYi Chen, Yuanzhen Zhang, Jun Huang, et al.
Journal of Medicinal Chemistry|October 24, 2018
Correction to Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-Negative BacteriaAleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, et al.
Journal of Medicinal Chemistry|June 15, 2016
Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular AtrophyMatthew G Woll, Hongyan Qi, Anthony Turpoff, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4BXiaoyan Zhang, Nanjing Zhang, Guangming Chen, et al.
Journal of Medicinal Chemistry|November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4BNanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Frontiers in Cellular and Infection Microbiology|July 19, 2021
Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura PhenotypesYuanzhen Zhang, Guizhi Xia, Xiaojing Nie, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replicationGuangming Chen, Hongyu Ren, Anthony Turpoff, et al.
Elife|February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrheaJana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4BGuangming Chen, Hongyu Ren, Nanjing Zhang, et al.
Journal of Medicinal Chemistry|May 5, 2018
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative BacteriaAleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, et al.
Molecular Genetics & Genomic Medicine|May 30, 2023
New insights from trio whole-exome sequencing in the children with kidney disease: A single-center retrospective cohort studyYi Chen, Yuanzhen Zhang, Jun Huang, et al.
Journal of Medicinal Chemistry|October 24, 2018
Correction to Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-Negative BacteriaAleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, et al.
Journal of Medicinal Chemistry|June 15, 2016
Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular AtrophyMatthew G Woll, Hongyan Qi, Anthony Turpoff, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4BXiaoyan Zhang, Nanjing Zhang, Guangming Chen, et al.
Journal of Medicinal Chemistry|November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4BNanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Pageof 16